Thus, it is important to identify HIPK2 as one of the CIN genes with different tumor-protective molecular activities, because it might facilitate to decipher the basis of heterogeneity of HIPK2 dysfunctions in different tissues and subsets of cancers. This evidence concerns the gene HIPK2 and cancer.